Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jesse Paul Babwah"'
Autor:
Jenna Sykes, Scott L. Boerner, Jesse Paul Babwah, Ming-Sound Tsao, Natasha B. Leighl, Cuihong Wei, Gilda da Cunha Santos, David M. Hwang, Suzanne Kamel-Reid, Carolyn J. Shiau, William R. Geddie
Publikováno v:
Journal of Thoracic Oncology. 9:947-956
Introduction: Epidermal growth factor receptor ( EGFR ) mutation testing has become critical in the treatment of patients with advanced non–small-cell lung cancer. This study involves a large cohort and epidemiologically unselected series of EGFR m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c888bcb310c71712179381c8771782b6
https://doi.org/10.1097/jto.0000000000000196
https://doi.org/10.1097/jto.0000000000000196
Autor:
May Griffiths-Turner, James B. Mahony, Jesse Paul Babwah, Daifallah Alnakhli, Tim O'Shea, William A Ciccotelli, Ron Goeree, Marek Smieja, Sonya Buracond, Gord Blackhouse, Sylvia Chong
Publikováno v:
Journal of Clinical Microbiology
We performed a cost analysis study using decision tree modeling to determine whether the use of multiplex PCR testing for respiratory viruses (xTAG RVP test) is a more or less costly strategy than the status quo testing methods used for the diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d60167106b20ed35dbcfdf95986db59
https://doi.org/10.1128/jcm.00556-09
https://doi.org/10.1128/jcm.00556-09
Publikováno v:
Archives of pathologylaboratory medicine. 138(11)
ContextAlong with the integration of immunohistochemical markers and molecular techniques into routine practice, addenda in surgical pathology reporting have not only increased in frequency but also evolved to include prognostic and therapeutic infor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a103f4dbcc9c18b3b16b9f29d9eea16
https://pubmed.ncbi.nlm.nih.gov/25357114
https://pubmed.ncbi.nlm.nih.gov/25357114
Autor:
Ming-Sound Tsao, Jenna Sykes, William R. Geddie, Scott Boerner, Jesse Paul Babwah, Cuihong Wei, Suzanne Kamel-Reid, David M. Hwang, Carolyn J. Shiau, Gilda da Cunha Santos
Publikováno v:
Journal of Clinical Oncology. 31:e19032-e19032
e19032 Background: Epidermal growth factor receptor (EGFR) mutation testing has become critical in the treatment of advanced non-small cell lung cancer (NSCLC) patients. This study involves a large cohort and epidemiologically unselected series of EG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85264c901a0acd4ac9dcbb715bcd26ae
https://doi.org/10.1200/jco.2013.31.15_suppl.e19032
https://doi.org/10.1200/jco.2013.31.15_suppl.e19032